Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostatic cancer [[electronic resource]]

• Pubblicazione: [Rockville, Md.] : , : [U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research], , [1999]
• Soggetto topico: Prostate - Cancer - Hormone therapy; Antiandrogens - Therapeutic use; Androgen Antagonists - therapeutic use; Cost-Benefit Analysis; Gonadotropin-Releasing Hormone - antagonists & inhibitors; Outcome Assessment, Health Care; Prostatic Neoplasms - drug therapy; Randomized Controlled Trials as Topic
• Note generali: Title from title screen (viewed on Apr. 29, 2004).; "January 1999."; "The full evidence report from which this summary was taken was prepared by the Evaluation Technology Center, an AHCPR Evidence-based Practice Center of the Blue Cross and Blue Shield Association, Chicago, Illinois, under contract no. 290-97-0015."
• Titolo autorizzato: Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostatic cancer
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910690658903321
• Lo trovi qui: Univ. Federico II